[1] 李小梅, 袁文茜, 曹伯旭, 等. 慢性癌症相关性疼痛[J]. 中国疼痛医学杂志, 2021, 27(3): 161-165. [2] Swarm RA, Paice JA, Anghelescu DL, et al.Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2019, 17(8): 977-1007. [3] Neufeld NJ, Elnahal SM, Alvarez RH.Cancer pain: A review of epidemiology, clinical quality and value impact[J]. Future Oncol, 2017, 13(9): 833-841. [4] Russo MM, Sundaramurthi RT.An overview of cancer pain: Epidemiology and pathophysiology[J]. Semin Oncol Nurs, 2019, 35(3):223-228. [5] Gao W, Gulliford M, Bennett MI, et al.Managing cancer pain at the end of life with multiple strong opioids:A population-based retrospective cohort study in primary care[J]. PLoS One, 2014, 9(1): e79266. [6] Zigmond AS, Snaith RP.The hospital anxiety and depression scale[J]. Acta Psychiatr Scand, 1983, 67(6): 361-370. [7] Hjermstad MJ, Fayers PM, Haugen DF, et al.Studies comparing numerical rating scales, verbal rating scales, and visual analogue scales for assessment of pain intensity in adults: A systematic literature review[J]. J Pain Symptom Manage, 2011, 41(6): 1073-1093. [8] Bennett MI, Kaasa S, Barke A, et al.The IASP classification of chronic pain for ICD-11: Chronic cancer-related pain[J]. Pain, 2019, 160(1): 38-44. [9] 国家中医药局办公室, 国家卫生健康委办公厅. 癌症疼痛诊疗规范(2018 年版)[J].全科医学临床与教育, 2019, 17(1):4-8. [10] Zhang C, Xiao J, Yu Z, et al.Cancer pain management and the roles of pharmacists in China[J]. Int J Clin Pharm, 2021, 43(2): 383-385. [11] Xu X, Luckett T, Wang AY, et al.Cancer pain management needs and perspectives of patients from Chinese backgrounds: A systematic review of the Chinese and English literature[J]. Palliat Support Care, 2018, 16(6): 785-799. [12] Bingel U, Wanigasekera V, Wiech K, et al. The effect of treatment expectation on drug efficacy:Imaging the analgesic benefit of the opioid remifentanil[J]. Sci Transl Med, 2011, 3(70): 70ra14. [13] 孙勇, 刘武, 张维, 等. 二甲双胍对2型糖尿病并发神经病理性疼痛大鼠的抗痛觉异常作用及机制研究[J]. 中华神经医学杂志, 2021, 20(12):1194-1203. [14] Fink RM, Gallagher E.Cancer pain assessment and measurement[J]. Semin Oncol Nurs, 2019, 35(3): 229-234. [15] Zebralla V, Wichmann G, Pirlich M, et al.Dysphagia, voice problems, and pain in head and neck cancer patients[J]. Eur Arch Otorhinolaryngol, 2021, 278(10): 3985-3994. [16] 王琦, 张文胜. 癌性疼痛的研究进展[J]. 国际麻醉学与复苏杂志, 2019, 40(4):383-387. [17] 王稳, 樊碧发. 癌痛发生机制的研究进展[J]. 中国疼痛医学杂志, 2021, 27(8):616-618. [18] Blanton HL, Brelsfoard J, DeTurk N, et al. Cannabinoids: Current and future options to treat chronic and chemotherapy-induced neuropathic pain[J]. Drugs, 2019, 79(9): 969-995. [19] Doo AR, Shin YS, Yoo S, et al.Radiation-induced neuropathic pain successfully treated with systemic lidocaine administration[J]. J Pain Res, 2018, 11: 545. |